6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
24m ago	Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
24m ago	Surface Transforms plc – in Administration, Sale of Business and Assets
24m ago	Guerbet: Changes to the Composition of Guerbet’s Board of Directors.
25m ago	RENAULT S.A. : disclosure of trading in own shares from May 15 to May 20, 2026
25m ago	Assystem: Combined General Meeting of 22 May 2026 - Voting Results and dividend for financial year 2025

About

0.39AUD-0.01 -1.28%

Closed • Updated at 16:59 GMT+00:00

Market Cap$50.64M

Volume79.8K

Beta1.75

RSI41.89

Gross Margin97.47%

Health TechnologyBiotechnology

Ltr Pharma Limited — investor relations, events, news, and company updates on 6ix.

Latest News

SPONTAN® Phase II interim data demonstrates rapid onset and pharmacokinetic profile addressing FDA Pre-IND requirements across adult and ≥65 populations

SPONTAN Phase II data show rapid onset, support FDA pathway

SPONTAN Phase II Clinical Study Completes Recruitment

Appendix 4D and Half Yearly Report

SPONTAN Shows Positive Outcomes in Younger Men with ED

Community Chat

Ask AI